CIRM Clinical Dashboard
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here
CIRM Clinical Dashboard
Disease Areas |
Investigator | Organization | Phase | Trial Status | Targeted Enrollment | Detail |
|---|---|---|---|---|---|---|
|
Thomas Kipps | University of California, San Diego | Phase 1/2 | Active, not recruiting | 160 | |
|
David Miklos | Stanford University | Phase 1 | Recruiting | 60 | |
|
Maria Grazia Roncarolo | Stanford University | Phase 1 | Recruiting | 22 | |
| Edward Kavalerchik | Angiocrine Bioscience, Inc. | Phase 1 | Active, not recruiting | 10 | ||
| Thomas Kipps | University of California, San Diego | Phase 1 | Completed | 26 | ||
| Irving Weissman | Stanford University | Phase 1 | Completed | 88 | ||
|
Michael Pulsipher | Children's Hospital of Los Angeles | Phase 1/2 | Active, not recruiting | 60 | |
| Edward Kavalerchik | Angiocrine Bioscience, Inc. | Phase 1 | Completed | 42 | ||
|
Mehrdad Abedi | University of California, Davis | Phase 1/2 | Recruiting | 18 | |
|
Colleen Delaney | Nohla Therapeutics Inc | Phase 2 | Closed | 146 | |
|
Mark Chao | Forty Seven Inc. | Phase 1 | Recruiting | 287 | |
|
Joseph Woodard | Immune-Onc Therapeutics | Phase 1 | Recruiting | 119 | |
|
Matthew Spear | Poseida Therapeutics, Inc. | Phase 1 | Active, not recruiting | 220 |
